Selection of Patients for Treatment of Brain Arteriovenous Malformations by the Transvenous Approach: Relationship with Venous Anatomy and Risk of Hemorrhagic Complications

References

1. 1.↵
   1. Choudhri O,
   2. Ivan ME,
   3. Lawton MT

   . Transvenous approach to intracranial arteriovenous malformations: challenging the axioms of arteriovenous malformation therapy? Neurosurgery 2015;77:644–51 doi:10.1227/NEU.0000000000000869 pmid:26120797

   CrossRefPubMed
2. 2.↵
   1. Mendes GA,
   2. Iosif C,
   3. Silveira EP, et al

   . Transvenous embolization in pediatric plexiform arteriovenous malformations. Neurosurgery 2016;78:458–65 doi:10.1227/NEU.0000000000001057 pmid:26457485

   CrossRefPubMed
3. 3.↵
   1. Mendes GA,
   2. Kalani MY,
   3. Iosif C, et al

   . Transvenous curative embolization of cerebral arteriovenous malformations: a prospective cohort study. Neurosurgery 2018;83:957–64 doi:10.1093/neuros/nyx581 pmid:29281075

   CrossRefPubMed
4. 4.↵
   1. Consoli A,
   2. Renieri L,
   3. Nappini S, et al

   . Endovascular treatment of deep hemorrhagic brain arteriovenous malformations with transvenous Onyx embolization. AJNR Am J Neuroradiol 2013;34:1805–11 doi:10.3174/ajnr.A3497 pmid:23557955

   Abstract/FREE Full Text
5. 5.↵
   1. Iosif C,
   2. Mendes GA,
   3. Saleme S, et al

   . Endovascular transvenous cure for ruptured brain arteriovenous malformations in complex cases with high Spetzler-Martin grades. J Neurosurg 2015;122:1229–38 doi:10.3171/2014.9.JNS141714 pmid:25794338

   CrossRefPubMed
6. 6.↵
   1. Haw CS,
   2. Terbrugge K,
   3. Willinsky R, et al

   . Complications of embolization of arteriovenous malformations of the brain. J Neurosurg 2006;104:226–32 doi:10.3171/jns.2006.104.2.226 pmid:16509496

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Subat YW,
   2. Dasenbrock HH,
   3. Gross BA, et al

   . Periprocedural intracranial hemorrhage after embolization of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg 2019 Sep 13. [Epub ahead of print] doi:10.3171/2019.5.JNS183204 pmid:31518979

   CrossRefPubMed
8. 8.↵
   1. Ledezma CJ,
   2. Hoh BL,
   3. Carter BS, et al

   . Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors. Neurosurgery 2006;58:602–11; discussion 602–11 doi:10.1227/01.NEU.0000204103.91793.77

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Saatci I,
   2. Geyik S,
   3. Yavuz K, et al

   . Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course—clinical article. J Neurosurg 2011;115:78–88 doi:10.3171/2011.2.JNS09830 pmid:21476804

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Potts MB,
    2. Jahangiri A,
    3. Jen M, et al

    ; UCSF Brain AVM Study Project. Deep arteriovenous malformations in the basal ganglia, thalamus, and insula: multimodality management, patient selection, and results. World Neurosurg 2014;82:386–94 doi:10.1016/j.wneu.2014.03.033 pmid:24657255

    CrossRefPubMed
11. 11.↵
    1. Pan J,
    2. He H,
    3. Feng L, et al

    . Angioarchitectural characteristics associated with complications of embolization in supratentorial brain arteriovenous malformation. AJNR Am J Neuroradiol 2014;35:354–59 doi:10.3174/ajnr.A3643 pmid:23886744

    Abstract/FREE Full Text
12. 12.
    1. Heros RC

    . Brain resection for exposure of deep extracerebral and paraventricular lesions. Surg Neurol 1990;34:188–95 doi:10.1016/0090-3019(90)90073-X pmid:2385826

    CrossRefPubMed
13. 13.
    1. Lawton MT,
    2. Hamilton MG,
    3. Spetzler RF

    . Multimodality treatment of deep arteriovenous malformations: thalamus, basal ganglia, and brain stem. Neurosurgery 1995;37:29–36 doi:10.1227/00006123-199507000-00004 pmid:8587687

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Liu KD,
    2. Lee LS

    . Microsurgical treatment of deep arteriovenous malformations: basal ganglia and thalamus. Zhonghua Yi Xue Za Zhi (Taipei) 2001;64:23–30 pmid:11310368

    PubMed
15. 15.↵
    1. Schaller C,
    2. Schramm J,
    3. Haun D

    . Significance of factors contributing to surgical complications and to late outcome after elective surgery of cerebral arteriovenous malformations. J Neurology Neurosurgery Psychiatry 1998;65:547–54 doi:10.1136/jnnp.65.4.547 pmid:9771782

    Abstract/FREE Full Text
16. 16.↵
    1. Schramm J,
    2. Schaller K,
    3. Esche J, et al

    . Microsurgery for cerebral arteriovenous malformations: subgroup outcomes in a consecutive series of 288 cases. J Neurosurg 2017;126:1056–63 doi:10.3171/2016.4.JNS153017 pmid:27285541

    CrossRefPubMed
17. 17.↵
    1. Chen CJ,
    2. Norat P,
    3. Ding D, et al

    . Transvenous embolization of brain arteriovenous malformations: a review of techniques, indications, and outcomes. Neurosurg Focus 2018;45:E13–17 doi:10.3171/2018.3.FOCUS18113

    CrossRefPubMed
18. 18.↵
    1. Baharvahdat H,
    2. Blanc R,
    3. Termechi R, et al

    . Hemorrhagic complications after endovascular treatment of cerebral arteriovenous malformations. AJNR Am J Neuroradiol 2014;35:978–83 doi:10.3174/ajnr.A3906 pmid:24676002

    Abstract/FREE Full Text
19. 19.↵
    1. Elsenousi A,
    2. Aletich VA,
    3. Alaraj A

    . Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis. J Neurointerv Surg 2016;8:265–72 doi:10.1136/neurintsurg-2014-011427 pmid:25540177

    Abstract/FREE Full Text
20. 20.↵
    1. Morgan MK,
    2. Wiedmann MK,
    3. Assaad NN, et al

    . Deliberate employment of postoperative hypotension for brain arteriovenous malformation surgery and the incidence of delayed postoperative hemorrhage: a prospective cohort study. J Neurosurg 2017;127:1025–40 doi:10.3171/2016.9.JNS161333 pmid:27982772

    CrossRefPubMed
21. 21.↵
    1. Niini T,
    2. Laakso A,
    3. Tanskanen P, et al

    . Perioperative treatment of brain arteriovenous malformations between 2006 and 2014: the Helsinki Protocol. Neurocrit Care 2019;31:346–56 doi:10.1007/s12028-019-00674-y pmid:30767121

    CrossRefPubMed
22. 22.↵
    1. Rangel-Castilla L,
    2. Spetzler RF,
    3. Nakaji P

    . Normal perfusion pressure breakthrough theory: a reappraisal after 35 years. Neurosurg Rev 2015;38:399–405 doi:10.1007/s10143-014-0600-4 pmid:25483235

    CrossRefPubMed
23. 23.↵
    1. Massoud TF,
    2. Hademenos GJ

    . Transvenous retrograde nidus sclerotherapy under controlled hypotension (TRENSH): a newly proposed treatment for brain arteriovenous malformations—Concepts and rationale. Neurosurgery 1999;45:351–65 doi:10.1097/00006123-199908000-00031 pmid:10449081

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Cronqvist M,
    2. Wirestam R,
    3. Ramgren B, et al

    . Endovascular treatment of intracerebral arteriovenous malformations: procedural safety, complications, and results evaluated by MR imaging, including diffusion and perfusion imaging. AJNR Am J Neuroradiol 2006;27:162–76 pmid:16418378

    Abstract/FREE Full Text
25. 25.↵
    1. Hartmann A,
    2. Pile-Spellman J,
    3. Stapf C, et al

    . Risk of endovascular treatment of brain arteriovenous malformations. Stroke 2002;33:1816–20 doi:10.1161/01.STR.0000020123.80940.B2 pmid:12105359

    Abstract/FREE Full Text
26. 26.↵
    1. Meisel HJ,
    2. Mansmann U,
    3. Alvarez H, et al

    . Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM. Acta Neurochir (Wien) 2002;144:879–88; discussion 888 doi:10.1007/s00701-002-0978-6 pmid:12376769

    CrossRefPubMedWeb of Science
27. 27.↵
    1. Cronqvist M,
    2. Ramgren B,
    3. Geijer B, et al

    . Diffusion- and perfusion-weighted MRI in therapeutic neurointerventional procedures. Neuroradiology 2001;43:662–71 doi:10.1007/s002340100543 pmid:11548175

    CrossRefPubMedWeb of Science